Page last updated: 2024-10-28

fasudil and Hepatitis C, Chronic

fasudil has been researched along with Hepatitis C, Chronic in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SH1
Moon, JS1
Pak, BY1
Kim, GW1
Lee, W1
Cho, H1
Kim, S1
Kim, SJ1
Oh, JW1

Other Studies

1 other study available for fasudil and Hepatitis C, Chronic

ArticleYear
HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice.
    Scientific reports, 2018, 08-20, Volume: 8, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antiviral Agents; Carbamates; Cell Line, Tum

2018